CIPLA.NS Profit & Loss
Cipla Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 9 years on file
(FY2017-18 to FY2025-26)
· fetched 2026-08-23 21:42
| Line item | FY2017-18 | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹15,219.25 Cr. | ₹16,362.41 Cr. | ₹17,131.99 Cr. | ₹19,159.59 Cr. | ₹21,763.34 Cr. | ₹22,753.12 Cr. | ₹25,774.09 Cr. | ₹27,547.62 Cr. | ₹28,162.59 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | ₹15,219.25 Cr. | ₹16,362.41 Cr. | ₹17,131.99 Cr. | ₹19,159.59 Cr. | ₹21,763.34 Cr. | ₹22,753.12 Cr. | ₹25,774.09 Cr. | ₹27,547.62 Cr. | N/A | SegmentRevenueFromOperations |
| Other Income | ₹357.65 Cr. | ₹476.57 Cr. | ₹344.20 Cr. | ₹265.99 Cr. | ₹280.91 Cr. | ₹475.45 Cr. | ₹746.57 Cr. | ₹861.87 Cr. | ₹882.01 Cr. | OtherIncome |
| Total Income | ₹15,576.90 Cr. | ₹16,838.98 Cr. | ₹17,476.19 Cr. | ₹19,425.58 Cr. | ₹22,044.25 Cr. | ₹23,228.57 Cr. | ₹26,520.66 Cr. | ₹28,409.49 Cr. | ₹29,044.60 Cr. | Income |
| Cost of Materials Consumed | ₹4,497.16 Cr. | ₹4,285.04 Cr. | ₹4,376.81 Cr. | ₹4,886.43 Cr. | ₹5,533.13 Cr. | ₹5,519.62 Cr. | ₹5,220.51 Cr. | ₹5,409.60 Cr. | ₹5,841.62 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹1,174.20 Cr. | ₹1,452.41 Cr. | ₹1,859.37 Cr. | ₹2,658.17 Cr. | ₹3,687.16 Cr. | ₹2,828.66 Cr. | ₹3,536.03 Cr. | ₹3,851.49 Cr. | ₹4,451.37 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-232.94 Cr. | ₹47.04 Cr. | ₹-244.76 Cr. | ₹-192.71 Cr. | ₹-724.69 Cr. | ₹-96.00 Cr. | ₹63.03 Cr. | ₹-332.10 Cr. | ₹-743.88 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹2,690.10 Cr. | ₹2,856.53 Cr. | ₹3,027.01 Cr. | ₹3,251.83 Cr. | ₹3,529.91 Cr. | ₹3,830.08 Cr. | ₹4,310.04 Cr. | ₹4,832.83 Cr. | ₹5,366.33 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹114.23 Cr. | ₹168.43 Cr. | ₹197.36 Cr. | ₹160.70 Cr. | ₹106.35 Cr. | ₹109.54 Cr. | ₹89.88 Cr. | ₹62.01 Cr. | ₹54.39 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹1,322.82 Cr. | ₹1,326.31 Cr. | ₹1,174.65 Cr. | ₹1,067.66 Cr. | ₹1,051.95 Cr. | ₹1,172.11 Cr. | ₹1,051.02 Cr. | ₹1,106.95 Cr. | ₹1,210.98 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹4,264.35 Cr. | ₹4,624.08 Cr. | ₹4,907.57 Cr. | ₹4,303.44 Cr. | ₹5,185.05 Cr. | ₹5,643.79 Cr. | ₹6,353.43 Cr. | ₹6,657.90 Cr. | ₹7,364.25 Cr. | OtherExpenses |
| Total Expenses | ₹13,829.92 Cr. | ₹14,759.84 Cr. | ₹15,298.01 Cr. | ₹16,135.52 Cr. | ₹18,368.86 Cr. | ₹19,007.80 Cr. | ₹20,623.94 Cr. | ₹21,588.68 Cr. | ₹23,545.06 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹1,746.98 Cr. | ₹2,079.14 Cr. | ₹2,178.18 Cr. | ₹3,290.06 Cr. | ₹3,675.39 Cr. | ₹4,220.77 Cr. | ₹5,896.72 Cr. | ₹6,820.81 Cr. | ₹5,499.54 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹-77.52 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹-182.12 Cr. | ₹-182.42 Cr. | ₹-194.82 Cr. | ₹0.00 Cr. | ₹-275.91 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹1,669.46 Cr. | ₹2,079.14 Cr. | ₹2,178.18 Cr. | ₹3,290.06 Cr. | ₹3,493.27 Cr. | ₹4,038.35 Cr. | ₹5,701.90 Cr. | ₹6,820.81 Cr. | ₹5,223.63 Cr. | ProfitBeforeTax |
| Tax Expense | ₹250.11 Cr. | ₹569.53 Cr. | ₹631.20 Cr. | ₹888.76 Cr. | ₹933.80 Cr. | ₹1,202.86 Cr. | ₹1,546.59 Cr. | ₹1,529.76 Cr. | ₹1,353.84 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹1,416.57 Cr. | ₹1,492.44 Cr. | ₹1,499.52 Cr. | ₹2,388.51 Cr. | ₹2,546.65 Cr. | ₹2,832.89 Cr. | ₹4,153.72 Cr. | ₹5,269.20 Cr. | ₹3,861.74 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹1,410.53 Cr. | ₹1,527.70 Cr. | ₹1,546.52 Cr. | ₹2,404.87 Cr. | ₹2,516.75 Cr. | ₹2,801.91 Cr. | ₹4,121.55 Cr. | ₹5,272.52 Cr. | ₹3,879.23 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹17.53 | ₹18.97 | ₹19.19 | ₹29.82 | ₹31.20 | ₹34.72 | ₹51.05 | ₹65.29 | ₹48.03 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹17.50 | ₹18.93 | ₹19.16 | ₹29.79 | ₹31.17 | ₹34.69 | ₹51.01 | ₹65.24 | ₹48.00 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from CIPLA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).